Author

F. Andre

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pathology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Assay:imaging· 1

Frequent Co-Authors

A. de Lavergne· 1 shared A. Dobric· 1 shared A. Jacquet· 1 shared A. Jaeger· 1 shared A. Jungmann· 1 shared A. Kamoun· 1 shared A. Sarrazin· 1 shared B. Krautz· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. de Lavergne

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cardiac-targeted rAAV5-S100A1 gene therapy protects against adverse remodeling and contractile dysfunction in post-ischemic hearts

D. Kehr, J. Salatzki, B. Krautz, K. Varadi, J. Birkenstock, P. Schlegel, E. Gao, W. J. Koch, J. Riffel, F. Andre, K. Peppel, H. A. Katus, N. Frey, M. Busch, H. Pfannkuche, , P. Most

This study demonstrates that cardiac-targeted rAAV5-S100A1 gene therapy reduces adverse remodeling and improves contractile function in post-ischemic hearts in pigs and mice.

bioRxiv · Mar 3, 2023 · PreprintPathology

Deep Learning Allows Assessment of Risk of Metastatic Relapse from Invasive Breast Cancer Histological Slides

I. Garberis, V. Gaury, C. Saillard, D. Drubay, K. Elgui, B. Schmauch, A. Jaeger, L. Herpin, J. Linhart, M. Sapateiro, F. Bernigole, A. Kamoun, E. Bendjebbar, A. de Lavergne, R. Dubois, , M. Lacroix-Triki

This paper develops a deep learning model to assess metastatic relapse risk in ER+/HER2-negative breast cancer patients using histological slides, showing improved prognostic performance over clinical factors.

bioRxiv · Nov 28, 2022Pathology

E-cadherin is a structuring component of invadopodia in pancreatic cancer

A. Dobric, S. Germain, F. Silvy, R. Bonier, S. Audebert, L. Camoin, N. J. Dusetti, P. Soubeyran, J. Iovanna, V. Rigot, F. Andre

This study identifies E-cadherin as a critical structural component of invadopodia in pancreatic cancer cells, showing its role in invadopodia formation and structuration through interactions with Arp2/3, Cortactin, and MT1-MMP.

bioRxiv · Oct 9, 2020Cancer Biology